Alnylam Pharmaceuticals, Inc. [ALNY]

John M. Maraganore Ph.D, President & CEO of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) rings over the closing bell.

John M. Maraganore Ph.D, President & CEO of Alnylam Pharmaceuticals, Inc. rings the closing bell.

John M. Maraganore Ph.D,
President & CEO
of Alnylam Pharmaceuticals, Inc.
rings the closing bell.

Friday, February 16, 2005
at NASDAQ's MarketSite
in New York City.

Alnylam Pharmaceuticals, Inc.

Additional Photographs & Reprint Permissions |
Archived MarketSite Events | Summary Quote

John M. Maraganore Ph.D, President & CEO of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) will preside over the closing bell.

About Alnylam Pharmaceuticals, Inc. [ALNY]:

Alnylam is a biotechnology company developing novel therapeutics that harness RNA interference, a mechanism for silencing disease-causing genes that is potentially the basis for a new class of medicines.

Reprints

Click for larger pictures of the NASDAQ MarketSite.

Additional Photographs for 02/16/2005

Download Hi-Res Quality Photo of this NASDAQ Market Open
- Pictured: Alnylam Pharmaceuticals, Inc. [ALNY] President & CEO Rings The NASDAQ Stock Market Closing Bell in celebration of the company's listing on The NASDAQ Stock Market.
These photos are Copyright 2005, Getty Images for The Nasdaq Stock Market Inc. and available for re-publication by the news media only. Any commercial use is strictly prohibited without the prior written consent of Getty Images and The Nasdaq Stock Market Inc.